RaiaDrogasil
RaiaDrogasil, a leading player in the Brazilian pharmaceutical retail sector, is headquartered in São Paulo, Brazil. Founded in 2011 through the merger of two prominent pharmacy chains, Raia and Drogasil, the company has rapidly expanded its footprint across major urban regions in Brazil, establishing itself as a trusted name in healthcare. Specialising in the sale of prescription medications, over-the-counter drugs, and health and beauty products, RaiaDrogasil distinguishes itself with a commitment to customer service and accessibility. The company operates a vast network of stores, ensuring that quality healthcare products are readily available to the public. With a strong market position, RaiaDrogasil has achieved significant milestones, including numerous awards for excellence in retail and customer satisfaction. Its dedication to innovation and community health initiatives further solidifies its reputation as a leader in the industry.
DitchCarbon Score
How does RaiaDrogasil's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
RaiaDrogasil's score of 30 is higher than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
RaiaDrogasil's reported carbon emissions
In 2022, RaiaDrogasil reported total carbon emissions of approximately 587,278,420 kg CO2e. This figure includes 29,051,290 kg CO2e from Scope 1 emissions, 7,795,260 kg CO2e from Scope 2 emissions, and a significant 553,206,930 kg CO2e from Scope 3 emissions, which encompass a wide range of activities including purchased goods and services, employee commuting, and waste generated in operations. The company's emissions have fluctuated over the years, with total emissions recorded at 40,859,700 kg CO2e in 2020 and 49,029,600 kg CO2e in 2021. Notably, the Scope 3 emissions have consistently represented the largest portion of their total emissions, indicating a substantial impact from their supply chain and product lifecycle. Despite these figures, RaiaDrogasil has not publicly committed to specific reduction targets or initiatives as part of their climate strategy. The absence of documented reduction targets suggests a need for further development in their climate commitments. As the company continues to operate within the pharmaceutical and retail sectors in Brazil, addressing these emissions will be crucial for aligning with global climate goals and enhancing sustainability practices.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|
| Scope 1 | 1,528,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000,000 | 0,000,000 |
| Scope 3 | 6,156,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
RaiaDrogasil is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
